Glucose Tolerance Test
Benefits at a glance
- Ready to use – solution
- Defined and comparable quality on high pharmaceutical standards
- Made in Germany, two API –sources, both from European manufacturers
- No alcohol and glycerol
- Aligned with the up-to-date guideline
Product details
Indication
Strengths
75g / 300ml
Dosage form
API
Regulatory approach
Dossier available
Turnover
Development by
Summary
Due to a tragic occurrence, were a 28 years old pregnant woman and her unborn child died in Cologne in September 2019 because of contaminated oGTT, the DDG (German Diabetis Society) and WHO recommended to have a standardized oral test for diabetes with a defined glucose solution.
Midas Pharma decided afterwards to start their development of two products à Glucose tolerance screening test (oGST) and the Glucose tolerance test (oGTT).
The MA was granted in September 2024 in Germany.
Your Contact
Heike Sagi
Business Development & Licensing
Senior Director
Rheinstraße 49
55218 Ingelheim
Germany
-
Disclaimer
The exploitation, including the development, sale and offer for sale of products and related processes is performed by Midas only in those territories where permissible by applicable patent law in particular, but not limited to EC Directive 2001/83 EC, Article 10, as amended by EC Directive 2004/27 EC. This document, therefore, does not and shall not constitute an offer for sale for the product in territories where an offer for sale or sale is not permissible by law. Midas expressly disclaims any liability for the information provided in this document as well as for damages resulting from or arising out of the use of the product and related process for purposes other than research and development in compliance with applicable laws.